- Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Active Rheumatoid Arthritis: The RAPID 2 Study. A Randomized, Controlled Trial.2009 | First Faculty of Medicine
- Certolizumab Pegol Plus Methotrexete Is Significantly More Effective Than Placebo Plus Methotrexate in Active Rheumatoid Arthritis.2008 | First Faculty of Medicine
- Efficacy and safety following repeated courses of Rituximab in patients with active rheumatoid arthritis.Publication without faculty affiliation
- Leflunomide in the therapy of active rheumatoid arthritis2004 | First Faculty of Medicine
- The place of leflunomide in the treatment of active rheumatoid arthritis2014 | Publication without faculty affiliation
- Safety and Tolerability of Rituximab Retreatment in Patiens with Active Rheumatoid ArthritisPublication without faculty affiliation
- Preliminary Efficacy Results of Rituximab Retreatment in Patiens with Active Rheumatoid ArthritisPublication without faculty affiliation
- Infiximab with methotrexatein active rheumatoid arthritis. Results of one-year pilot studyPublication without faculty affiliation
- Impact of a Series of Methylprednisolone Minipulses in the Treatment of Active Rheumatoid Arthritis1994 | First Faculty of Medicine
- Energy expenditure at rest in patients with active rheumatoid arthritis and malnutrition1993 | Second Faculty of Medicine
- A double-blind study of Etanercept and metotrexate (MTX), alone and combined, in patients with active rheumatoid arthritis (tempo trial) - 3 years resultsPublication without faculty affiliation
- Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study2013 | First Faculty of Medicine
- Therapy of active rheumatoid arthritis with infliximab and methotrexate. Results of one- year open studyPublication without faculty affiliation
- A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis2005 | First Faculty of Medicine
- A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis2005 | Faculty of Physical Education and Sport
- Experiences with leflunomide (ARAVA) treatment for active rheumatoid arthritis at clinical practice in the Czech Republic (evaluation of the patients from the Czech rheumatology association register2005 | First Faculty of Medicine
- Double-Blind Comparison of Etanercept and Sulfasalazine, Alone and Combined in Patients with Active Rheumatoid Arthritis. Clinical effects of PralnacasanPublication without faculty affiliation
- Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein2018 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey2018 | First Faculty of Medicine
- Clinical Outcomes of a Double-Blind Study of Etanercept and Methotrexate, Alone and Combined, in Patiens with Active Rheumatoid Arthritis (TEMPO Trial), Year 2 Results.Publication without faculty affiliation
- Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice2012 | First Faculty of Medicine
- Skin explant model assay - A tool for detection of autoaggression in patients with rheumatoid arthritis1999 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study2019 | First Faculty of Medicine
- Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access2017 | First Faculty of Medicine
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis2011 | First Faculty of Medicine
- Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs2012 | First Faculty of Medicine
- Unusual development of rheumatoid arthritis - case report2019 | Publication without faculty affiliation
- Efficacy and safety of certolizumab pegol in the treatment of rheumatoid arthritis2011 | First Faculty of Medicine
- Monitoring of the serum biomarkers during the therapy period of the patients with rheumatoid arthritis. Pilot Study2016 | Faculty of Medicine in Pilsen
- Biological therapy in Rheumatology2016 | First Faculty of Medicine